Sony is launching the Xyn (pronounced zin), an “extended reality” headset for creating 3D objects for films, animation, and games. The device, which Sony first teased at CES last year ...
Codenamed ‘XYN’, the company says it’s targeting creators looking to make spatial content. Update (January 9th, 2025): A previous version of this article reported that XYN was a rebadging of ...
XYN Spatial capture solution will convert high-quality, photorealistic 3D CG assets from real-world objects and spaces using images captured by mirrorless cameras and proprietary algorithms ...
SAN DIEGO, Jan. 6, 2025 /PRNewswire/ -- Sony Electronics Inc. ("Sony") announced the launch of "XYN Motion Studio *1," as the first product under Sony's new brand ...
Sony has unveiled a prototype headset it’s calling “an immersive spatial content creation system”. It comes with 4K OLED displays and supports 3D production and character modelling.
At CES, Sony showed off a prototype of the XYN VR headset. This is a headset that the company says will help in the creation of spatial content. It comes equipped with 4K OLED microdisplays with ...
Among these are XYN, a pioneering headset for creating 3D objects, a new vehicle filming system, and tech to improve sports fans' experience. Thaisa Yamamura, head of XR Business Development at ...
New year, new headset. Sony just launched its latest virtual reality headset, XYN, alongside software applications of the same name, the Japanese brand announced on Monday at the Consumer ...
XYN Motion Studio is a PC application which supports connections with 12 "mocopi®" sensors and utilizes Sony's proprietary algorithms for automatic motion interpolation and auto-tagging functions ...
SAN DIEGO, Jan. 6, 2025 /PRNewswire/ -- Sony Electronics Inc. ("Sony") announced the launch of "XYN Motion Studio *1," as the first product under Sony's new brand "XYN™ *2 (/zin/)," which integrates ...
Madrigal said that all patients enrolled in MAESTRO-NASH - which include up to 2,000 in total - are continuing on therapy after the initial 52-week treatment period.